Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
Status:
Recruiting
Trial end date:
2023-12-22
Target enrollment:
Participant gender:
Summary
This is an open-label, randomised study in participants with chronic kidney disease (CKD)
treated for hyperkalaemia (HK) whilst in hospital. The study will compare SZC to standard of
care (SoC) with the goal of determining:
- If continued use of SZC maintains normokalaemia (NK) better than SoC after participant
discharge from the hospital.
- If continued use of SZC after discharge will reduce HK related healthcare resource
utilisation compared to SoC.